Flugen INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMadison, WI
SAM.gov UEIM9FHAR3RBML5
FluGen Inc. develops influenza vaccines, with M2SR as its flagship candidate—an intranasal, supra-seasonal flu vaccine designed to stimulate mucosal, humoral, and cellular immunity. The company is advancing M2SR toward clinical application to address limitations in current flu prevention, including annual virus drift and vaccine shedding, and is exploring potential applications of the M2SR Vaccine Platform for other respiratory diseases including COVID-19 and RSV.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Flugen INC | Madison | WI | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.